[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Liquid Biopsy Market Research Report by Product (CTCs and ctDNA and Exosome), by End User (Clinical Diagnostic Laboratories, Hospitals, and Physician’s Office Laboratories) - Global Forecast to 2025 - Cumulative Impact of COVID-19

February 2021 | 196 pages | ID: L29ADC898F9DEN
360iResearch

US$ 3,949.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Liquid Biopsy Market is expected to grow from USD 984.66 Million in 2020 to USD 2,386.07 Million by the end of 2025.
2. The Global Liquid Biopsy Market is expected to grow from EUR 863.36 Million in 2020 to EUR 2,092.16 Million by the end of 2025.
3. The Global Liquid Biopsy Market is expected to grow from GBP 767.53 Million in 2020 to GBP 1,859.93 Million by the end of 2025.
4. The Global Liquid Biopsy Market is expected to grow from JPY 105,088.19 Million in 2020 to JPY 254,655.19 Million by the end of 2025.
5. The Global Liquid Biopsy Market is expected to grow from AUD 1,429.85 Million in 2020 to AUD 3,464.90 Million by the end of 2025.

Market Segmentation & Coverage:
This research report categorizes the Liquid Biopsy to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the Liquid Biopsy Market studied across CTCs and ctDNA and Exosome.

Based on End User, the Liquid Biopsy Market studied across Clinical Diagnostic Laboratories, Hospitals, and Physician’s Office Laboratories.

Based on Geography, the Liquid Biopsy Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Liquid Biopsy Market including CellMax Life, Exosome Diagnostics, QIAGEN, Roche Molecular Diagnostics, and Thermo Fisher Scientific.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Liquid Biopsy Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Liquid Biopsy Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Liquid Biopsy Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Liquid Biopsy Market?
4. What is the competitive strategic window for opportunities in the Global Liquid Biopsy Market?
5. What are the technology trends and regulatory frameworks in the Global Liquid Biopsy Market?
6. What are the modes and strategic moves considered suitable for entering the Global Liquid Biopsy Market?
1. PREFACE

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders

2. RESEARCH METHODOLOGY

2.1. Research Process
  2.1.1. Define: Research Objective
  2.1.2. Determine: Research Design
  2.1.3. Prepare: Research Instrument
  2.1.4. Collect: Data Source
  2.1.5. Analyze: Data Interpretation
  2.1.6. Formulate: Data Verification
  2.1.7. Publish: Research Report
  2.1.8. Repeat: Report Update
2.2. Research Execution
  2.2.1. Initiation: Research Process
  2.2.2. Planning: Develop Research Plan
  2.2.3. Execution: Conduct Research
  2.2.4. Verification: Finding & Analysis
  2.2.5. Publication: Research Report
2.3. Research Outcome

3. EXECUTIVE SUMMARY

3.1. Introduction
3.2. Market Outlook
3.3. Product Outlook
3.4. End User Outlook
3.5. Geography Outlook
3.6. Competitor Outlook

4. MARKET OVERVIEW

4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. MARKET INSIGHTS

5.1. Market Dynamics
  5.1.1. Drivers
  5.1.2. Restraints
  5.1.3. Opportunities
  5.1.4. Challenges
5.2. Porters Five Forces Analysis
  5.2.1. Threat of New Entrants
  5.2.2. Threat of Substitutes
  5.2.3. Bargaining Power of Customers
  5.2.4. Bargaining Power of Suppliers
  5.2.5. Industry Rivalry

6. GLOBAL LIQUID BIOPSY MARKET, BY PRODUCT

6.1. Introduction
6.2. CTCs and ctDNA
6.3. Exosome

7. GLOBAL LIQUID BIOPSY MARKET, BY END USER

7.1. Introduction
7.2. Clinical Diagnostic Laboratories
7.3. Hospitals
7.4. Physician’s Office Laboratories

8. AMERICAS LIQUID BIOPSY MARKET

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. ASIA-PACIFIC LIQUID BIOPSY MARKET

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. South Korea
9.10. Thailand

10. EUROPE, MIDDLE EAST & AFRICA LIQUID BIOPSY MARKET

10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom

11. COMPETITIVE LANDSCAPE

11.1. FPNV Positioning Matrix
  11.1.1. Quadrants
  11.1.2. Business Strategy
  11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis
11.4. Competitor SWOT Analysis
11.5. Competitive Scenario
  11.5.1. Merger & Acquisition
  11.5.2. Agreement, Collaboration, & Partnership
  11.5.3. New Product Launch & Enhancement
  11.5.4. Investment & Funding
  11.5.5. Award, Recognition, & Expansion

12. COMPANY USABILITY PROFILES

12.1. CellMax Life
12.2. Exosome Diagnostics
12.3. QIAGEN
12.4. Roche Molecular Diagnostics
12.5. Thermo Fisher Scientific

13. APPENDIX

13.1. Discussion Guide
13.2. License & Pricing

LIST OF TABLES

TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL LIQUID BIOPSY MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL LIQUID BIOPSY MARKET SIZE, BY CTCS AND CTDNA, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL LIQUID BIOPSY MARKET SIZE, BY EXOSOME, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL LIQUID BIOPSY MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL LIQUID BIOPSY MARKET SIZE, BY HOSPITALS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL LIQUID BIOPSY MARKET SIZE, BY PHYSICIAN’S OFFICE LABORATORIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. AMERICAS LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. AMERICAS LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. AMERICAS LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. ARGENTINA LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. ARGENTINA LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. BRAZIL LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. BRAZIL LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. CANADA LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. CANADA LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. MEXICO LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. MEXICO LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. UNITED STATES LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. UNITED STATES LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. ASIA-PACIFIC LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. ASIA-PACIFIC LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. ASIA-PACIFIC LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. AUSTRALIA LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. AUSTRALIA LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. CHINA LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. CHINA LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. INDIA LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. INDIA LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. INDONESIA LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. INDONESIA LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. JAPAN LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. JAPAN LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. MALAYSIA LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. MALAYSIA LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. PHILIPPINES LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. PHILIPPINES LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. SOUTH KOREA LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. SOUTH KOREA LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. THAILAND LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. THAILAND LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. EUROPE, MIDDLE EAST & AFRICA LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. EUROPE, MIDDLE EAST & AFRICA LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. FRANCE LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 49. FRANCE LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 50. GERMANY LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 51. GERMANY LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 52. ITALY LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 53. ITALY LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 54. NETHERLANDS LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 55. NETHERLANDS LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 56. QATAR LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 57. QATAR LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 58. RUSSIA LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 59. RUSSIA LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 60. SAUDI ARABIA LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 61. SAUDI ARABIA LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 62. SOUTH AFRICA LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 63. SOUTH AFRICA LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 64. SPAIN LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 65. SPAIN LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 66. UNITED ARAB EMIRATES LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 67. UNITED ARAB EMIRATES LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 68. UNITED KINGDOM LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 69. UNITED KINGDOM LIQUID BIOPSY MARKET SIZE, BY END USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 70. GLOBAL LIQUID BIOPSY MARKET: SCORES
TABLE 71. GLOBAL LIQUID BIOPSY MARKET: BUSINESS STRATEGY
TABLE 72. GLOBAL LIQUID BIOPSY MARKET: PRODUCT SATISFACTION
TABLE 73. GLOBAL LIQUID BIOPSY MARKET: RANKING
TABLE 74. GLOBAL LIQUID BIOPSY MARKET: MERGER & ACQUISITION
TABLE 75. GLOBAL LIQUID BIOPSY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 76. GLOBAL LIQUID BIOPSY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 77. GLOBAL LIQUID BIOPSY MARKET: INVESTMENT & FUNDING
TABLE 78. GLOBAL LIQUID BIOPSY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 79. GLOBAL LIQUID BIOPSY MARKET: LICENSE & PRICING


LIST OF FIGURES

FIGURE 1. GLOBAL LIQUID BIOPSY MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL LIQUID BIOPSY MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL LIQUID BIOPSY MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2020 (USD MILLION)
FIGURE 5. GLOBAL LIQUID BIOPSY MARKET SIZE, BY END USER, 2020 (USD MILLION)
FIGURE 6. GLOBAL LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 7. GLOBAL LIQUID BIOPSY MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 8. GLOBAL LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 9. GLOBAL LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 11. GLOBAL LIQUID BIOPSY MARKET: MARKET DYNAMICS
FIGURE 12. GLOBAL LIQUID BIOPSY MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 13. GLOBAL LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2020 VS 2025 (%)
FIGURE 14. GLOBAL LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2020 VS 2025 (USD MILLION)
FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL LIQUID BIOPSY MARKET SIZE, BY PRODUCT, 2025
FIGURE 16. GLOBAL LIQUID BIOPSY MARKET SIZE, BY CTCS AND CTDNA, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL LIQUID BIOPSY MARKET SIZE, BY EXOSOME, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL LIQUID BIOPSY MARKET SIZE, BY END USER, 2020 VS 2025 (%)
FIGURE 19. GLOBAL LIQUID BIOPSY MARKET SIZE, BY END USER, 2020 VS 2025 (USD MILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL LIQUID BIOPSY MARKET SIZE, BY END USER, 2025
FIGURE 21. GLOBAL LIQUID BIOPSY MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL LIQUID BIOPSY MARKET SIZE, BY HOSPITALS, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL LIQUID BIOPSY MARKET SIZE, BY PHYSICIAN’S OFFICE LABORATORIES, 2020 VS 2025 (USD MILLION)
FIGURE 24. AMERICAS LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 25. AMERICAS LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 26. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 27. ARGENTINA LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 28. BRAZIL LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 29. CANADA LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 30. MEXICO LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 31. UNITED STATES LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 32. ASIA-PACIFIC LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 33. ASIA-PACIFIC LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 35. AUSTRALIA LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 36. CHINA LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 37. INDIA LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 38. INDONESIA LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. JAPAN LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. MALAYSIA LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. PHILIPPINES LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. SOUTH KOREA LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. THAILAND LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. EUROPE, MIDDLE EAST & AFRICA LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 45. EUROPE, MIDDLE EAST & AFRICA LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 46. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 47. FRANCE LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 48. GERMANY LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 49. ITALY LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 50. NETHERLANDS LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. QATAR LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. RUSSIA LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. SAUDI ARABIA LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. SOUTH AFRICA LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. SPAIN LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. UNITED ARAB EMIRATES LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. UNITED KINGDOM LIQUID BIOPSY MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. GLOBAL LIQUID BIOPSY MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 59. GLOBAL LIQUID BIOPSY MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 60. GLOBAL LIQUID BIOPSY MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 61. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL LIQUID BIOPSY MARKET, BY TYPE


More Publications